# Unveiling stages of change among medical inpatients with an increased-risk alcohol consumption—a cross-sectional study

**Authors:** Maria Seferowicz, Anners Lerdal, Hilde Marie Erøy Edvardsen, Ragnhild Bergene Skråstad, Jørgen Valeur, Benedicte Marie Jørgenrud, Anna Armika Tussilago Nyman, Stig Tore Bogstrand

PMC · DOI: 10.1093/alcalc/agaf067 · Alcohol and Alcoholism (Oxford, Oxfordshire) · 2025-11-22

## TL;DR

This study explores how medical inpatients with different levels of alcohol consumption are distributed across stages of change, finding that increased-risk drinkers are most likely to be actively reducing their drinking.

## Contribution

The study identifies increased-risk drinkers as the largest group in the 'action' stage of change, offering insights for healthcare professionals and future research.

## Key findings

- Distributions of stages of change differ between low, increased, and high-risk alcohol consumers.
- Increased-risk consumers make up the majority in the 'action' stage, linked to reduced drinking.
- SOC distribution is consistent whether measured by AUDIT-C or phospatidylethanol biomarker.

## Abstract

Alcohol-related harm occurs at lower levels than previously recognized, warranting a need to identify mediators to reduce alcohol-associated risk in increased-risk drinkers. Stages of change (SOC) have been used to assess motivation for health behaviour alteration. The primary aim was to explore distribution on SOC among medical inpatients when comparing low-risk, increased-risk, and high-risk consumers as defined by Alcohol Use Disorder Identification Test-Consumption (AUDIT-C). Our secondary aim was to assess the distribution of SOC when consumption was stratified with a biomarker of alcohol use—phospatidylethanol 16:0/18:1.

Cross-sectional study with three participating hospitals. Recruiting consecutive medical inpatients ≥18 years with regular alcohol consumption as screened by score ≥2 on the first question in AUDIT-C (N = 888). AUDIT-C score and SOC were assessed by questionnaires, and phospatidylethanol concentration in a blood sample. Odds ratios and the 95% confidence intervals were calculated through a univariate logistic regression analysis for each variable, and multivariable logistic regression models were then fit to calculate the adjusted odds ratio and 95% confidence interval.

Distributions of SOC differed between the three risk-groups. Distribution of SOC was comparable whether assessed by phospatidylethanol or AUDIT-C.

Increased-risk consumers constitute the majority of those in action—the only stage associated with consecutive reduction in drinking. Potentially, these results can aid in reducing perceived barriers among health care professionals in screening and offering health advice to those with increased-risk consumption and inform further research on mediators in this subgroup.

Short Summary: Alcohol-related harm occurs at lower levels than previously recognized. This study investigated the distribution of groups with low, increased, and high-risk consumption in stages of change. Increased-risk consumers constitute the majority of those in action—the stage associated with consecutive reduction in drinking.

## Full-text entities

- **Diseases:** Alcohol Use Disorder (MESH:D000437)
- **Chemicals:** Alcohol (MESH:D000438), phospatidylethanol (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12640199/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12640199/full.md

## References

58 references — full list in the complete paper: https://tomesphere.com/paper/PMC12640199/full.md

---
Source: https://tomesphere.com/paper/PMC12640199